bookmark

Lorcaserin in obesity: minimal benefits and ill-defined harms | BMJ Evidence-Based Medicine

https://ebm.bmj.com/content/early/2019/01/29/bmjebm-2018-111128?rss=1

Description

Lorcaserin has recently been hailed in news media as the new ‘holy grail’ in managing obesity. Is this true? Or are we being misled? To read the full article, log in using your MPFT NHS OpenAthens details.

Preview

Users

Comments and Reviewsshow / hide

Please log in to take part in the discussion (add own reviews or comments).

BibSonomy